Plus Therapeutics Inc (PSTV) — Cash Flow Quality Index

Latest as of June 2025: -1.13x

Plus Therapeutics Inc (PSTV) has a Cash Flow Quality Index of -1.13x as of June 2025. Operating cash flow of $-5.80 Million is below net income of $5.15 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PSTV cash flow conversion to assess how effectively this company generates cash.

Cash Flow Quality Index

-1.13x

Operating CF / Net Income

Operating Cash Flow

$-5.80 Million

USD

Net Income

$5.15 Million

USD

Data as of

Jun 2025

Most recent filing

Annual Cash Flow Quality Index for Plus Therapeutics Inc (None–None)

Year-by-year earnings quality comparison for Plus Therapeutics Inc. For live market cap and the full company financial profile, see market cap of Plus Therapeutics Inc.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.